Literature DB >> 201777

Two methyltransferase activities in the purified virions of vesicular stomatitis virus.

D Testa, A K Banerjee.   

Abstract

In addition to an RNA-dependent RNA polymerase, purified vesicular stomatitis virus contains a methyltransferase activity which transfers the methyl group from the methyl donor, S-adenosyl-L-methionine, to two positions in the 5'-terminal capped structure of the nascent mRNA's synthesized in vitro as 7mG-(5)'ppp(5')Apm... In the present study it is shown that two distinct methyltransferase activities are discernible in the purified virus. The in vitro concentrations of the methyl donor specify the number and location of the methyl groups transferred to the capped 5'-termini of VSV mRNA's. Limited concentrations of the methyl donor result in a single methylation of the penultimate base in the 2'-hydroxyl position, that is, G(5')ppp(5')Apm..., whereas saturating concentrations of the methyl donor methylate the blocking guanosine residue at the 7-position, resulting in the dimethylated cap, 7mG(5')ppp(5')Apm... Pulse-chase experiments demonstrate that the monomethylated cap structure is the precursor substrate for the dimethylated cap. In this respect, vesicular stomatitis virus system is quite distinct from the vaccinia and reovirus systems. Virus purified from different host cells including hamster, mouse, and human contain both methyltransferase activities. The mRNA's containing monomethylated capped structures are poor templates for protein synthesis in vitro.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 201777      PMCID: PMC516000     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Influence of 5'-terminal m7G and 2'--O-methylated residues on messenger ribonucleic acid binding to ribosomes.

Authors:  S Muthukrishnan; M Morgan; A K Banerjee; A J Shatkin
Journal:  Biochemistry       Date:  1976-12-28       Impact factor: 3.162

2.  The nature of the RNA products synthesized in vitro by subviral components of visicular stomatitis virus.

Authors:  G Abraham; A K Banerjee
Journal:  Virology       Date:  1976-05       Impact factor: 3.616

3.  Mapping and initiation studies on the leader RNA of vesicular stomatitis virus.

Authors:  R J Colonno; A K Banerjee
Journal:  Virology       Date:  1977-03       Impact factor: 3.616

4.  Effect of 5'-terminal structure and base composition on polyribonucleotide binding to ribosomes.

Authors:  G W Both; Y Furuichi; S Muthukrishnan; A J Shatkin
Journal:  J Mol Biol       Date:  1976-07-05       Impact factor: 5.469

5.  In vitro synthesis of RNA that contains polyadenylate by virion-associated RNA polymerase of vesicular stomatitis virus.

Authors:  A K Banerjee; D P Rhodes
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

6.  Studies on the in vitro adenylation of RNA by vesicular stomatitis virus.

Authors:  A K Banerjee; S A Moyer; D P Rhodes
Journal:  Virology       Date:  1974-10       Impact factor: 3.616

7.  Ribonucleic acid synthesis of vesicular stomatitis virus, II. An RNA polymerase in the virion.

Authors:  D Baltimore; A S Huang; M Stampfer
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

8.  In vitro synthesis of RNA containing 5'-terminal structure 7nG(5')ppp(5')Apm... by purified wound tumor virus.

Authors:  D P Rhodes; D V Reddy; R MacLeod; L M Black; A K Banerjee
Journal:  Virology       Date:  1977-02       Impact factor: 3.616

9.  Mechanism of formation of reovirus mRNA 5'-terminal blocked and methylated sequence, m7GpppGmpC.

Authors:  Y Furuichi; S Muthukrishnan; J Tomasz; A J Shatkin
Journal:  J Biol Chem       Date:  1976-08-25       Impact factor: 5.157

10.  A unique RNA species involved in initiation of vesicular stomatitis virus RNA transcription in vitro.

Authors:  R J Colonno; A K Banerjee
Journal:  Cell       Date:  1976-06       Impact factor: 41.582

View more
  38 in total

Review 1.  An unconventional pathway of mRNA cap formation by vesiculoviruses.

Authors:  Tomoaki Ogino; Amiya K Banerjee
Journal:  Virus Res       Date:  2011-09-16       Impact factor: 3.303

Review 2.  In vitro capping and transcription of rhabdoviruses.

Authors:  Tomoaki Ogino
Journal:  Methods       Date:  2012-06-08       Impact factor: 3.608

Review 3.  Polymerases of paramyxoviruses and pneumoviruses.

Authors:  Rachel Fearns; Richard K Plemper
Journal:  Virus Res       Date:  2017-01-16       Impact factor: 3.303

Review 4.  Transcription and replication of rhabdoviruses.

Authors:  A K Banerjee
Journal:  Microbiol Rev       Date:  1987-03

5.  S-adenosyl homocysteine-induced hyperpolyadenylation of vesicular stomatitis virus mRNA requires the methyltransferase activity of L protein.

Authors:  Summer E Galloway; Gail W Wertz
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

6.  Identification of sendai virus L protein amino acid residues affecting viral mRNA cap methylation.

Authors:  Andrea M Murphy; Valery Z Grdzelishvili
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

7.  Sequence-function analysis of the Sendai virus L protein domain VI.

Authors:  Andrea M Murphy; Megan Moerdyk-Schauwecker; Arcady Mushegian; Valery Z Grdzelishvili
Journal:  Virology       Date:  2010-07-06       Impact factor: 3.616

8.  Interaction of the C-terminal domains of sendai virus N and P proteins: comparison of polymerase-nucleocapsid interactions within the paramyxovirus family.

Authors:  Klaartje Houben; Dominique Marion; Nicolas Tarbouriech; Rob W H Ruigrok; Laurence Blanchard
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

Review 9.  Flavivirus methyltransferase: a novel antiviral target.

Authors:  Hongping Dong; Bo Zhang; Pei-Yong Shi
Journal:  Antiviral Res       Date:  2008-06-05       Impact factor: 5.970

10.  A temperature sensitive VSV identifies L protein residues that affect transcription but not replication.

Authors:  Summer E Galloway; Gail W Wertz
Journal:  Virology       Date:  2009-04-22       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.